Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
10-Dec-2025 | 5,672 | 5,727.5 | 5,577 | 5,598.5 | 13,101 | 44,70,41,724.5 | 51,038 |
11-Dec-2025 | 5,584 | 5,670.5 | 5,577 | 5,626 | 9,387 | 35,88,96,136.5 | 40,266 |
12-Dec-2025 | 5,666 | 5,676 | 5,587.5 | 5,631 | 8,832 | 20,16,73,379 | 19,637 |
15-Dec-2025 | 5,611 | 5,632.5 | 5,579.5 | 5,624.5 | 6,538 | 12,21,23,803 | 11,588 |
16-Dec-2025 | 5,601 | 5,678.5 | 5,584 | 5,663.5 | 13,347 | 52,80,53,360 | 59,474 |
17-Dec-2025 | 5,660 | 5,697.5 | 5,577.5 | 5,628.5 | 10,044 | 20,28,55,667.5 | 18,946 |
18-Dec-2025 | 5,628.5 | 5,629.5 | 5,504 | 5,521 | 8,150 | 19,30,62,077.5 | 13,551 |
19-Dec-2025 | 5,506 | 5,593 | 5,499 | 5,555.5 | 7,867 | 28,68,61,838 | 31,717 |
22-Dec-2025 | 5,555.5 | 5,654.5 | 5,555.5 | 5,624 | 12,862 | 46,30,48,893.5 | 52,440 |
23-Dec-2025 | 5,611 | 5,660 | 5,560.5 | 5,597 | 9,859 | 15,86,97,384.5 | 13,547 |
24-Dec-2025 | 5,570 | 5,593 | 5,534 | 5,566 | 6,613 | 22,93,75,604.5 | 20,989 |
26-Dec-2025 | 5,539 | 5,581 | 5,508 | 5,535 | 6,813 | 22,34,64,347.5 | 20,774 |
29-Dec-2025 | 5,573 | 5,573 | 5,481 | 5,505 | 8,499 | 21,58,59,782.5 | 20,114 |
30-Dec-2025 | 5,485 | 5,496.5 | 5,405 | 5,469 | 36,225 | 79,37,57,573.5 | 84,062 |
31-Dec-2025 | 5,450 | 5,528.5 | 5,426.5 | 5,506.5 | 9,278 | 20,60,00,038.5 | 21,750 |
01-Jan-2026 | 5,477 | 5,519.5 | 5,384 | 5,463.5 | 8,166 | 24,13,97,416 | 12,575 |
02-Jan-2026 | 5,498 | 5,600 | 5,448.5 | 5,592.5 | 8,886 | 20,90,16,313 | 20,448 |
05-Jan-2026 | 5,599 | 5,616.5 | 5,531.5 | 5,552.5 | 13,517 | 23,41,02,859.5 | 25,954 |
06-Jan-2026 | 5,554.5 | 5,679.5 | 5,554.5 | 5,655.5 | 16,042 | 48,38,48,272.5 | 48,484 |
07-Jan-2026 | 5,675 | 5,833 | 5,634.5 | 5,806.5 | 31,029 | 1,09,12,96,208 | 96,316 |
08-Jan-2026 | 5,805.5 | 5,847.5 | 5,763.5 | 5,793 | 18,024 | 77,37,59,557 | 90,229 |
09-Jan-2026 | 5,775.5 | 5,825 | 5,707 | 5,799 | 19,091 | 77,72,35,541.5 | 78,771 |
This inspection, conducted from March 10 through March 13, 2025, was to evaluate compliance with the legal standards concerning bioequivalence studies.
The company saw its revenues increase by 1.5% YoY at ₹3,374 crore from ₹3,324 crore.
The serum contains liposomal azelaic acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide.
R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.
According to sources, the floor price would be ₹5,616 per share, which is 3% lower than the current market price (CMP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
